APO Research
Talk to an analyst

APO RESEARCH · REPORT

Weight-loss Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Weight-loss Drugs Market Outlook and Growth Opportunities 2026

19 December 2025200 pages

Choose your research edition.

Industry ResearchWeight-loss Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Weight-loss Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Weight-loss Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Weight-loss Drugs Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Weight-loss Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Weight-loss Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Weight-loss Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Weight-loss Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Weight-loss Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Weight-loss Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Weight-loss Drugs market include Ajinomoto Co. Inc., Amway Corp., Currax, Glanbia PLC, GlaxoSmithKline PLC, Health and Nutrition Ltd., Herbalife Nutrition Ltd., Kellogg Company and Kraft Heinz Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Weight-loss Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Weight-loss Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Weight-loss Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Weight-loss Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Weight-loss Drugs Segment by Company

Ajinomoto Co. Inc.

Amway Corp.

Currax

Glanbia PLC

GlaxoSmithKline PLC

Health and Nutrition Ltd.

Herbalife Nutrition Ltd.

Kellogg Company

Kraft Heinz Company

Novo Nordisk

PepsiCo

Roar Ambition

Swiss Research Labs Ltd.

Ultimate life ltd

Wolfson Berg Ltd

Nestle

Abbott

Weight-loss Drugs Segment by Type

Powder

Softgels

Pills

Liquid

Others

Weight-loss Drugs Segment by Application

Hospitals and Clinics

Pharmacy

Online Sales

Others

Weight-loss Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Weight-loss Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Weight-loss Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Weight-loss Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Weight-loss Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight-loss Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Weight-loss Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight-loss Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Weight-loss Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Weight-loss Drugs industry.

Chapter 3: Detailed analysis of Weight-loss Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Weight-loss Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Weight-loss Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Weight-loss Drugs Industry Trends Table 2. Weight-loss Drugs Industry Drivers Table 3. Weight-loss Drugs Industry Opportunities and Challenges Table 4. Weight-loss Drugs Industry Restraints Table 5. Global Weight-loss Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Weight-loss Drugs Revenue Share by Company (2021-2026) Table 7. Global Weight-loss Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Weight-loss Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Weight-loss Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Weight-loss Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Weight-loss Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Weight-loss Drugs Company, Product Type & Application Table 13. Global Weight-loss Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Weight-loss Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Powder Table 18. Significant Companies of Softgels Table 19. Significant Companies of Pills Table 20. Significant Companies of Liquid Table 21. Significant Companies of Others Table 22. Global Weight-loss Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Weight-loss Drugs Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Weight-loss Drugs Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Weight-loss Drugs Sales Volume Share by Type (2021-2026) Table 26. Global Weight-loss Drugs Sales Volume Share by Type (2027-2032) Table 27. Global Weight-loss Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Weight-loss Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Weight-loss Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Weight-loss Drugs Sales Value Share by Type (2021-2026) Table 31. Global Weight-loss Drugs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospitals and Clinics Table 33. Significant Companies of Pharmacy Table 34. Significant Companies of Online Sales Table 35. Significant Companies of Others Table 36. Global Weight-loss Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Weight-loss Drugs Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Weight-loss Drugs Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Weight-loss Drugs Sales Volume Share by Application (2021-2026) Table 40. Global Weight-loss Drugs Sales Volume Share by Application (2027-2032) Table 41. Global Weight-loss Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Weight-loss Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Weight-loss Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Weight-loss Drugs Sales Value Share by Application (2021-2026) Table 45. Global Weight-loss Drugs Sales Value Share by Application (2027-2032) Table 46. Global Weight-loss Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Weight-loss Drugs Sales by Region (2021-2026) & (K Units) Table 48. Global Weight-loss Drugs Sales Market Share by Region (2021-2026) Table 49. Global Weight-loss Drugs Sales by Region (2027-2032) & (K Units) Table 50. Global Weight-loss Drugs Sales Market Share by Region (2027-2032) Table 51. Global Weight-loss Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Weight-loss Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Weight-loss Drugs Sales Value Share by Region (2021-2026) Table 54. Global Weight-loss Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Weight-loss Drugs Sales Value Share by Region (2027-2032) Table 56. Global Weight-loss Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Weight-loss Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Weight-loss Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Weight-loss Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Weight-loss Drugs Sales by Country (2021-2026) & (K Units) Table 61. Global Weight-loss Drugs Sales Market Share by Country (2021-2026) Table 62. Global Weight-loss Drugs Sales by Country (2027-2032) & (K Units) Table 63. Global Weight-loss Drugs Sales Market Share by Country (2027-2032) Table 64. Global Weight-loss Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Weight-loss Drugs Sales Value Market Share by Country (2021-2026) Table 66. Global Weight-loss Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Weight-loss Drugs Sales Value Market Share by Country (2027-2032) Table 68. Ajinomoto Co. Inc. Company Information Table 69. Ajinomoto Co. Inc. Business Overview Table 70. Ajinomoto Co. Inc. Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Ajinomoto Co. Inc. Weight-loss Drugs Product Portfolio Table 72. Ajinomoto Co. Inc. Recent Development Table 73. Amway Corp. Company Information Table 74. Amway Corp. Business Overview Table 75. Amway Corp. Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Amway Corp. Weight-loss Drugs Product Portfolio Table 77. Amway Corp. Recent Development Table 78. Currax Company Information Table 79. Currax Business Overview Table 80. Currax Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Currax Weight-loss Drugs Product Portfolio Table 82. Currax Recent Development Table 83. Glanbia PLC Company Information Table 84. Glanbia PLC Business Overview Table 85. Glanbia PLC Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Glanbia PLC Weight-loss Drugs Product Portfolio Table 87. Glanbia PLC Recent Development Table 88. GlaxoSmithKline PLC Company Information Table 89. GlaxoSmithKline PLC Business Overview Table 90. GlaxoSmithKline PLC Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline PLC Weight-loss Drugs Product Portfolio Table 92. GlaxoSmithKline PLC Recent Development Table 93. Health and Nutrition Ltd. Company Information Table 94. Health and Nutrition Ltd. Business Overview Table 95. Health and Nutrition Ltd. Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Health and Nutrition Ltd. Weight-loss Drugs Product Portfolio Table 97. Health and Nutrition Ltd. Recent Development Table 98. Herbalife Nutrition Ltd. Company Information Table 99. Herbalife Nutrition Ltd. Business Overview Table 100. Herbalife Nutrition Ltd. Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Herbalife Nutrition Ltd. Weight-loss Drugs Product Portfolio Table 102. Herbalife Nutrition Ltd. Recent Development Table 103. Kellogg Company Company Information Table 104. Kellogg Company Business Overview Table 105. Kellogg Company Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Kellogg Company Weight-loss Drugs Product Portfolio Table 107. Kellogg Company Recent Development Table 108. Kraft Heinz Company Company Information Table 109. Kraft Heinz Company Business Overview Table 110. Kraft Heinz Company Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Kraft Heinz Company Weight-loss Drugs Product Portfolio Table 112. Kraft Heinz Company Recent Development Table 113. Novo Nordisk Company Information Table 114. Novo Nordisk Business Overview Table 115. Novo Nordisk Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Novo Nordisk Weight-loss Drugs Product Portfolio Table 117. Novo Nordisk Recent Development Table 118. PepsiCo Company Information Table 119. PepsiCo Business Overview Table 120. PepsiCo Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. PepsiCo Weight-loss Drugs Product Portfolio Table 122. PepsiCo Recent Development Table 123. Roar Ambition Company Information Table 124. Roar Ambition Business Overview Table 125. Roar Ambition Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Roar Ambition Weight-loss Drugs Product Portfolio Table 127. Roar Ambition Recent Development Table 128. Swiss Research Labs Ltd. Company Information Table 129. Swiss Research Labs Ltd. Business Overview Table 130. Swiss Research Labs Ltd. Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Swiss Research Labs Ltd. Weight-loss Drugs Product Portfolio Table 132. Swiss Research Labs Ltd. Recent Development Table 133. Ultimate life ltd Company Information Table 134. Ultimate life ltd Business Overview Table 135. Ultimate life ltd Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Ultimate life ltd Weight-loss Drugs Product Portfolio Table 137. Ultimate life ltd Recent Development Table 138. Wolfson Berg Ltd Company Information Table 139. Wolfson Berg Ltd Business Overview Table 140. Wolfson Berg Ltd Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Wolfson Berg Ltd Weight-loss Drugs Product Portfolio Table 142. Wolfson Berg Ltd Recent Development Table 143. Nestle Company Information Table 144. Nestle Business Overview Table 145. Nestle Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Nestle Weight-loss Drugs Product Portfolio Table 147. Nestle Recent Development Table 148. Abbott Company Information Table 149. Abbott Business Overview Table 150. Abbott Weight-loss Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Abbott Weight-loss Drugs Product Portfolio Table 152. Abbott Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Weight-loss Drugs Distributors List Table 156. Weight-loss Drugs Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Weight-loss Drugs Product Image Figure 2. Global Weight-loss Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Weight-loss Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Weight-loss Drugs Sales (2021-2032) & (K Units) Figure 5. Global Weight-loss Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Weight-loss Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Powder Image Figure 10. Softgels Image Figure 11. Pills Image Figure 12. Liquid Image Figure 13. Others Image Figure 14. Global Weight-loss Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Weight-loss Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Weight-loss Drugs Sales Volume Share by Type (2021-2032) Figure 17. Global Weight-loss Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Weight-loss Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Weight-loss Drugs Sales Value Share by Type (2021-2032) Figure 20. Hospitals and Clinics Image Figure 21. Pharmacy Image Figure 22. Online Sales Image Figure 23. Others Image Figure 24. Global Weight-loss Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Weight-loss Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Weight-loss Drugs Sales Volume Share by Application (2021-2032) Figure 27. Global Weight-loss Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Weight-loss Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Weight-loss Drugs Sales Value Share by Application (2021-2032) Figure 30. Global Weight-loss Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Weight-loss Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Weight-loss Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Weight-loss Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Weight-loss Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. North America Weight-loss Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Weight-loss Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Weight-loss Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Weight-loss Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Weight-loss Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Weight-loss Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. South America Weight-loss Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Weight-loss Drugs Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Weight-loss Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Weight-loss Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Weight-loss Drugs Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Weight-loss Drugs Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Softgels
  • Pills
  • Liquid
  • Others
Applications
  • Hospitals and Clinics
  • Pharmacy
  • Online Sales
  • Others
Companies covered
  • Ajinomoto Co. Inc.
  • Amway Corp.
  • Currax
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Health and Nutrition Ltd.
  • Herbalife Nutrition Ltd.
  • Kellogg Company
  • Kraft Heinz Company
  • Novo Nordisk
  • PepsiCo
  • Roar Ambition
  • Swiss Research Labs Ltd.
  • Ultimate life ltd
  • Wolfson Berg Ltd
  • Nestle
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Weight-loss Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Weight-loss Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Weight-loss Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Weight-loss Drugs Market Dynamics
  1. 2.1 Weight-loss Drugs Industry Trends
  2. 2.2 Weight-loss Drugs Industry Drivers
  3. 2.3 Weight-loss Drugs Industry Opportunities and Challenges
  4. 2.4 Weight-loss Drugs Industry Restraints
3 Weight-loss Drugs Market by Company
  1. 3.1 Global Weight-loss Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Weight-loss Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Weight-loss Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Weight-loss Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Weight-loss Drugs Company Ranking (2024-2026)
  6. 3.6 Global Weight-loss Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Weight-loss Drugs Company Product Type and Application
  8. 3.8 Global Weight-loss Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Weight-loss Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Weight-loss Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Weight-loss Drugs Market by Type
  1. 4.1 Weight-loss Drugs Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Softgels
  4. 4.1.3 Pills
  5. 4.1.4 Liquid
  6. 4.1.5 Others
  7. 4.2 Global Weight-loss Drugs Sales Volume by Type
  8. 4.2.1 Global Weight-loss Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Weight-loss Drugs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Weight-loss Drugs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Weight-loss Drugs Sales Value by Type
  12. 4.3.1 Global Weight-loss Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Weight-loss Drugs Sales Value by Type (2021-2032)
  14. 4.3.3 Global Weight-loss Drugs Sales Value Share by Type (2021-2032)
5 Weight-loss Drugs Market by Application
  1. 5.1 Weight-loss Drugs Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Pharmacy
  4. 5.1.3 Online Sales
  5. 5.1.4 Others
  6. 5.2 Global Weight-loss Drugs Sales Volume by Application
  7. 5.2.1 Global Weight-loss Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Weight-loss Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Weight-loss Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Weight-loss Drugs Sales Value by Application
  11. 5.3.1 Global Weight-loss Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Weight-loss Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Weight-loss Drugs Sales Value Share by Application (2021-2032)
6 Weight-loss Drugs Regional Sales and Value Analysis
  1. 6.1 Global Weight-loss Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Weight-loss Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Weight-loss Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Weight-loss Drugs Sales by Region (2027-2032)
  5. 6.3 Global Weight-loss Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Weight-loss Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Weight-loss Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Weight-loss Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Weight-loss Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Weight-loss Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Weight-loss Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Weight-loss Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Weight-loss Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Weight-loss Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Weight-loss Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Weight-loss Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Weight-loss Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Weight-loss Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Weight-loss Drugs Sales Value Share by Country, 2025 VS 2032
7 Weight-loss Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Weight-loss Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Weight-loss Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Weight-loss Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Weight-loss Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Weight-loss Drugs Sales by Country (2027-2032)
  6. 7.4 Global Weight-loss Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Weight-loss Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Weight-loss Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Weight-loss Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Weight-loss Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Weight-loss Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajinomoto Co. Inc.
  2. 8.1.1 Ajinomoto Co. Inc. Company Information
  3. 8.1.2 Ajinomoto Co. Inc. Business Overview
  4. 8.1.3 Ajinomoto Co. Inc. Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ajinomoto Co. Inc. Weight-loss Drugs Product Portfolio
  6. 8.1.5 Ajinomoto Co. Inc. Recent Developments
  7. 8.2 Amway Corp.
  8. 8.2.1 Amway Corp. Company Information
  9. 8.2.2 Amway Corp. Business Overview
  10. 8.2.3 Amway Corp. Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amway Corp. Weight-loss Drugs Product Portfolio
  12. 8.2.5 Amway Corp. Recent Developments
  13. 8.3 Currax
  14. 8.3.1 Currax Company Information
  15. 8.3.2 Currax Business Overview
  16. 8.3.3 Currax Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Currax Weight-loss Drugs Product Portfolio
  18. 8.3.5 Currax Recent Developments
  19. 8.4 Glanbia PLC
  20. 8.4.1 Glanbia PLC Company Information
  21. 8.4.2 Glanbia PLC Business Overview
  22. 8.4.3 Glanbia PLC Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Glanbia PLC Weight-loss Drugs Product Portfolio
  24. 8.4.5 Glanbia PLC Recent Developments
  25. 8.5 GlaxoSmithKline PLC
  26. 8.5.1 GlaxoSmithKline PLC Company Information
  27. 8.5.2 GlaxoSmithKline PLC Business Overview
  28. 8.5.3 GlaxoSmithKline PLC Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline PLC Weight-loss Drugs Product Portfolio
  30. 8.5.5 GlaxoSmithKline PLC Recent Developments
  31. 8.6 Health and Nutrition Ltd.
  32. 8.6.1 Health and Nutrition Ltd. Company Information
  33. 8.6.2 Health and Nutrition Ltd. Business Overview
  34. 8.6.3 Health and Nutrition Ltd. Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Health and Nutrition Ltd. Weight-loss Drugs Product Portfolio
  36. 8.6.5 Health and Nutrition Ltd. Recent Developments
  37. 8.7 Herbalife Nutrition Ltd.
  38. 8.7.1 Herbalife Nutrition Ltd. Company Information
  39. 8.7.2 Herbalife Nutrition Ltd. Business Overview
  40. 8.7.3 Herbalife Nutrition Ltd. Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Herbalife Nutrition Ltd. Weight-loss Drugs Product Portfolio
  42. 8.7.5 Herbalife Nutrition Ltd. Recent Developments
  43. 8.8 Kellogg Company
  44. 8.8.1 Kellogg Company Company Information
  45. 8.8.2 Kellogg Company Business Overview
  46. 8.8.3 Kellogg Company Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kellogg Company Weight-loss Drugs Product Portfolio
  48. 8.8.5 Kellogg Company Recent Developments
  49. 8.9 Kraft Heinz Company
  50. 8.9.1 Kraft Heinz Company Company Information
  51. 8.9.2 Kraft Heinz Company Business Overview
  52. 8.9.3 Kraft Heinz Company Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Kraft Heinz Company Weight-loss Drugs Product Portfolio
  54. 8.9.5 Kraft Heinz Company Recent Developments
  55. 8.10 Novo Nordisk
  56. 8.10.1 Novo Nordisk Company Information
  57. 8.10.2 Novo Nordisk Business Overview
  58. 8.10.3 Novo Nordisk Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novo Nordisk Weight-loss Drugs Product Portfolio
  60. 8.10.5 Novo Nordisk Recent Developments
  61. 8.11 PepsiCo
  62. 8.11.1 PepsiCo Company Information
  63. 8.11.2 PepsiCo Business Overview
  64. 8.11.3 PepsiCo Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 PepsiCo Weight-loss Drugs Product Portfolio
  66. 8.11.5 PepsiCo Recent Developments
  67. 8.12 Roar Ambition
  68. 8.12.1 Roar Ambition Company Information
  69. 8.12.2 Roar Ambition Business Overview
  70. 8.12.3 Roar Ambition Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Roar Ambition Weight-loss Drugs Product Portfolio
  72. 8.12.5 Roar Ambition Recent Developments
  73. 8.13 Swiss Research Labs Ltd.
  74. 8.13.1 Swiss Research Labs Ltd. Company Information
  75. 8.13.2 Swiss Research Labs Ltd. Business Overview
  76. 8.13.3 Swiss Research Labs Ltd. Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Swiss Research Labs Ltd. Weight-loss Drugs Product Portfolio
  78. 8.13.5 Swiss Research Labs Ltd. Recent Developments
  79. 8.14 Ultimate life ltd
  80. 8.14.1 Ultimate life ltd Company Information
  81. 8.14.2 Ultimate life ltd Business Overview
  82. 8.14.3 Ultimate life ltd Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Ultimate life ltd Weight-loss Drugs Product Portfolio
  84. 8.14.5 Ultimate life ltd Recent Developments
  85. 8.15 Wolfson Berg Ltd
  86. 8.15.1 Wolfson Berg Ltd Company Information
  87. 8.15.2 Wolfson Berg Ltd Business Overview
  88. 8.15.3 Wolfson Berg Ltd Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Wolfson Berg Ltd Weight-loss Drugs Product Portfolio
  90. 8.15.5 Wolfson Berg Ltd Recent Developments
  91. 8.16 Nestle
  92. 8.16.1 Nestle Company Information
  93. 8.16.2 Nestle Business Overview
  94. 8.16.3 Nestle Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Nestle Weight-loss Drugs Product Portfolio
  96. 8.16.5 Nestle Recent Developments
  97. 8.17 Abbott
  98. 8.17.1 Abbott Company Information
  99. 8.17.2 Abbott Business Overview
  100. 8.17.3 Abbott Weight-loss Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Abbott Weight-loss Drugs Product Portfolio
  102. 8.17.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Weight-loss Drugs Value Chain Analysis
  2. 9.1.1 Weight-loss Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Weight-loss Drugs Sales Mode & Process
  6. 9.2 Weight-loss Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Weight-loss Drugs Distributors
  9. 9.2.3 Weight-loss Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst